Member Info for Tatty99

For what it’s worth Paul Emmit I did say at the AGM that he planned to host a visit for shareholders to see the new test system in Bridgend. He seemed to think that would be before the next AGM!

The revolving door keeps on turning and the list former of execs and non execs keeps growing. It’s as though there is some dark secret which keeps driving them away.

Sajy can’t imagine a big pharma making an upfront 750m payment which is 10x the current mcap. It would make more sense just to buy the company as a whole.

This really does stink and without outside support, this litigation could drain the lifeblood out of PHE. I hope the Chairmans’s experience is as good as he claims.

Very poor grades Au

A goof buy? You could be right!

Reading the HUI RNS comes across as they are p*ssed off with PHE and also f*ck you PHE because the cannabis business will provide all the funds we need.

Both companies have been hopeless at getting anything actually built.

Ironically probably an honest RNS. Focus on getting ONE system built and working first. You can’t commit to more projects without a working system first. And on that point PHE will run out of cash before that happens. I’d like to know what income has been earned by Engsolve.

A very positive review and recommendation. It will come good but will probably take a couple of years. Somewhat muted response from the market first thing. Should end the day significantly higher.

......nor is Paul Emmitt.

That said it all for me.

So hydrogen does or does not have a future? A bit like PHE?

Noix I agree with the comment it seems too good to be true but the facts show it does appear to be good and true.

However it is still puzzling why the Phase 2b trial results in that FT link are from March 2021, so a long gap to be where we are today. A bit disappointing no one had the appetite to fund a Phase 3 trial yet.

It would appear that FDA provided fast track designation back in 2018?

https://pharmaceutical-business-review.com/news/destiny-pharma-gets-fda-fast-track-designation-for-exeporfinium-chloride-to-prevent-post-surgical-staphylococcal-infections-160318-6085567/

Interesting to see the POG graph started to rise the day before the current crisis in the middle east kicked off. Some coincidence that.

Why so long between announcing the Phase 3 Plans Finalisation and kicking off the Phase 3 process itself?

Obviously GGP has been a terrible investment for the last 2-3 years, but is it a good investment now for future benefits? What's the outlook for the gold price?

Surely this is the product with the biggest potential yet they seem to downplay it somewhat?

Nothing new in this but the cash position is positive.

Ledzep I think your analysis of the current situation is spot on and I’m out for now and until there is more positive and credible news, which may be a while off now. TTFN

For me if PHE fail to produce a new working demonstrator by 31st March 2024, then I can’t see how they can survive as a credible and competent business. Paul and his team have to deliver.

Paxatran - mea culpa - I clearly don't know what year it is! Yes I meant 2024 NOT 2025. Thanks for querying it needs to be correct.